ProNova Solutions

ProNova Solutions is a forward-thinking biotechnology startup that aims to revolutionize cancer treatment. Established in 2011, the company's mission is to make Proton Therapy more accessible to a wider range of patients and physicians worldwide. ProNova is committed to developing the next generation of advanced cancer treatment, focusing on creating a lower-cost, smaller, lighter, and more energy-efficient solution without compromising performance. This innovative approach incorporates state-of-the-art imaging, multi-axis precision positioning, superconducting magnet technology, and closed-loop treatment verification using Positron Emission Tomography. These advancements offer significant benefits to ProNova's customers, enhancing clinical, operational, and financial aspects. The last significant investment came in the form of a $2.70M Convertible Note in November 17, 2014. ProNova's steadfast dedication to improving patient care, outcomes, and value makes it a promising prospect for investors in the healthcare and biotechnology sectors.